Showing 2,392 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Money

Progress with HIV undercut by lack of food or shelter

Editor's pick
San Francisco Chronicle
27 April 2012
New & experimental hepatitis C treatment

US: do not mix Merck hepatitis pill with HIV drugs

Editor's pick
Reuters
27 April 2012
New & experimental HIV treatments

Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir

Editor's pick
NATAP
20 April 2012
Undetectable viral load & treatment as prevention

Guidance on couples HIV testing and counselling, including antiretroviral therapy for treatment and prevention in serodiscordant couples

Editor's pick
World Health Organization
20 April 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
Government, leadership & policy

Three Big HIV Days in May at the FDA

Editor's pick
AIDSMeds
19 April 2012
Undetectable viral load & treatment as prevention

Breaking: WHO issues new guidance for discordant couples

Editor's pick
Science Speaks
18 April 2012
Treatment guidelines

Nepal: Treatment illiteracy puts HIV benchmarks in peril

Editor's pick
PlusNews
17 April 2012
Side effects

Why it's time to say goodbye to stavudine...everywhere

Editor's pick
South African Journal of HIV Medicine
16 April 2012
New & experimental HIV treatments

DFH Pharma to Collaborate with National Institutes of Health to Develop 2nd Generation HIV Maturation Inhibitor Drugs

Editor's pick
PR Newswire
16 April 2012
Drug interactions & pharmacokinetics

Genetic testing for drug intolerance

Editor's pick
The Guardian
16 April 2012
Side effects

CROI: Crofelemer Reduces Diarrhea in People with HIV; FDA Grants Priority Review

Editor's pick
HIVandHepatitis.com
13 April 2012
The search for a cure

Engineering CD8 Cells to Kill HIV in Tissues

Editor's pick
AIDSMeds
13 April 2012
Side effects

Can I Get A Witness! Authentic Voices Tell the Story of Neuropathy

Editor's pick
The Body
12 April 2012
HIV prevention policy

Translators fight the fatal effects of the language gap

Editor's pick
The Guardian
11 April 2012
Bone & joint problems

CROI: Switching to Tenofovir Increases Bone Turnover, Raltegravir Can Improve Bone Density

Editor's pick
HIVandHepatitis.com
11 April 2012
Pharmaceutical industry

Gilead And The Future of HIV Therapy

Editor's pick
The Street
10 April 2012
New & experimental hepatitis C treatment

What You Don’t Know, You Can Sell: Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients

Editor's pick
TAG
10 April 2012
Pregnancy and vertical transmission

WHO updates HIV treatment guidance for pregnant women and preventing HIV infection in babies

Editor's pick
Science Speaks
10 April 2012
Treatment guidelines

Q and A: Why are US and UK treatment guidelines different?

Editor's pick
HIV i-Base
5 April 2012
New & experimental hepatitis C treatment

Revised U.S. Guidelines Make Key HIV and Hep C Treatment Recommendations

Editor's pick
AIDSMeds
3 April 2012
New & experimental hepatitis C treatment

Copy of Revised U.S. Guidelines Make Key HIV and Hep C Treatment Recommendations

Editor's pick
Kaiser Daily Global Health Policy Report
3 April 2012
New & experimental HIV treatments

GSK's new once-daily HIV drug matches Merck rival

Editor's pick
Reuters
2 April 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study

Editor's pick
ViiV Healthcare (press release)
2 April 2012